SiMAG-active - terminal reactive groups allow the
convenient and efficient covalent binding of bioaffine ligands. This
is a unique feature accounting for the rapidly increasing number and
variation of novel and different receptor-affine biological
substances.
See:
Coupling-Protocols
| Application: | Activated particles for custom-made covalent binding of biological substances | |
| Formulation: | suspension in ddH2O, autoclaved | |
| Concentration: | 50 mg/ml | |
| Particle sizes: | 0.5 µm, 0.75 µm, 1.0 µm | |
| Functional Group | Product Number | Quantity (ml) | Price EUR / USD |
Activation / Coupling | Product Information | Reference Number |
|---|---|---|---|---|---|---|
|
SiMAG-Amine |
1401-1 1401-5 |
1 5 |
35 / 46 140 / 182 |
Carbodiimide method Mannich reaction see coupling protocol: A2/3 |
1.02,
1.16,
1.30, 1.32, 1.47, 5.06 |
|
|
SiMAG-Carboxyl |
1402-1 1402-5 |
1 5 |
35 / 46 140 / 182 |
Carbodiimide method see coupling protocol: A1 |
1.02,
1.10,
1.16, 1.21, 1.23, 1.24, 1.31, 1.34, 1.47, 1.54, 1.57, 3.02, 5.03, 5.05, 5.06, 5.12 |
|
|
SiMAG-Cyanuric |
1403-1 1403-5 |
1 5 |
35 / 46 140 / 182 |
Cyanuric chloride, auto-reactive see coupling protocol: A8 |
1.47, 2.10 | |
|
SiMAG-Hydrazide |
1404-1 1404-5 |
1 5 |
35 / 46 140 / 182 |
Oxidized carbohydrats see coupling protocol: A5 |
1.23,
1.47,
1.49, 2.06, 2.09 |
|
|
SiMAG-Hydroxyl |
1405-1 1405-5 |
1 5 |
35 / 46 140 / 182 |
Cyanogen bromide activation see coupling protocol: A7 |
1.42, 1.47 | |
SiMAG-PGL
|
1406-1 1406-5 |
1 5 |
35 / 46 140 / 182 |
For covalent coupling of bioligands, see coupling protocol: A4 |
1.47, 3.12 | |
|
SiMAG-Thiol |
1407-1 1407-5 |
1 5 |
35 / 46 140 / 182 |
Maleimides | 1.18, 1.47 | |
|
SiMAG-Bromoacetyl |
1408-1 1408-5 |
1 5 |
35 / 46 140 / 182 |
For binding of SH-groups containing bioligands see coupling protocol: A14 |
- | |
|
SiMAG-Chitosan |
1409-1 1409-5 |
1 5 |
35 / 46 140 / 182 |
For separation of peptides and enzymes, selective binding of metal ions |
- |